Graft options in posterolateral and posterior interbody lumbar fusion

Spine

Volumn 35, Issue 17, 2010, Pages 1629-1639

  Rihn, Jeffrey A ^a   Kirkpatrick, Kelly ^b   Albert, Todd J ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b VILLANOVA UNIVERSITY   (United States)

Author keywords

bone morphogenetic protein; DBM; demineralized bone matrix; lumbar fusion; platelet gel

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE CERAMIC; COLLAGEN TYPE 1; DURASEALXACT SEALANT SYSTEM; HEALOS; HYDROXYAPATITE; OSTEOGENIC PROTEIN 1; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1; SEALANT; UNCLASSIFIED DRUG;

ANTERIOR SPINE FUSION; AUTOGRAFT; BONE ATROPHY; BONE DEVELOPMENT; BONE GRAFT; BONE GROWTH; BONE MARROW BIOPSY; BONE MATRIX; BONE SCREW; CELL DIFFERENTIATION; CERAMICS; CLINICAL TRIAL; COMPARATIVE STUDY; COMPRESSION OSTEOSYNTHESIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DONOR SITE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HETEROTOPIC OSSIFICATION; HOSPITALIZATION; HUMAN; ILIAC BONE; INFLAMMATION; LUMBAR SPINE; MATRIX ATTACHMENT REGION; MEDICAL LITERATURE; MORBIDITY; MULTICENTER STUDY; NONHUMAN; OFF LABEL DRUG USE; PARESTHESIA; PATIENT SAFETY; PILOT STUDY; POROSITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PSEUDARTHROSIS; RADICULITIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPINAL CORD ATROPHY; SPINAL CORD DECOMPRESSION; SPINAL HEMATOMA; SPINE FUSION; SPINE RADIOGRAPHY; SPINE SURGERY; SPONDYLOLISTHESIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT RESPONSE;

BONE MORPHOGENETIC PROTEINS; BONE SUBSTITUTES; BONE TRANSPLANTATION; HUMANS; LUMBAR VERTEBRAE; SPINAL FUSION;

EID: 77955469730     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181d25803     Document Type: Review

References (56)

1. Weinstein JN, Lurie JD, Olson PR, et al. United States' trends and regional variations in lumbar spine surgery: 1992-2003. Spine 2006;31:2707-2714
2. Herkowitz HN, Kurz LT. Degenerative lumbar spondylolisthesis with spinal stenosis. A prospective study comparing decompression with decompression and intertransverse process arthrodesis. J Bone Joint Surg Am 1991;73: 802-808
3. Zdeblick TA. A prospective, randomized study of lumbar fusion. Preliminary results. Spine (Phila Pa 1976) 1993;18:983-991
4. Thomsen K, Christensen FB, Eiskjaer SP, et al. 1997 Volvo Award winner in clinical studies. The effect of pedicle screw instrumentation on functional outcome and fusion rates in posterolateral lumbar spinal fusion: a prospective, randomized clinical study. Spine (Phila Pa 1976) 1997;22:2813-2822
5. Fischgrund JS, Mackay M, Herkowitz HN, et al. 1997 Volvo Award winner in clinical studies. Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation. Spine 1997;22: 2807-2812
6. Vaccaro AR, Whang PG, Patel T, et al. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J 2008;8: 457-465
7. Glassman SD, Dimar JR III, Burkus K, et al. The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers. Spine 2007;32:1693-1698
8. Dimar JR, Glassman SD, Burkus KJ, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 2006;31:2534-9; discussion 2540.
9. Dimar JR II, Glassman SD, Burkus JK, et al. Two-year fusion and clinical outcomes in 224 patients treated with a single-level instrumented posterolateral fusion with iliac crest bone graft. Spine J 2009;9:880-885
10. Summers BN, Eisenstein SM. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br 1989;71:677-680
11. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 1995;20:1055-1060
12. Silber JS, Anderson DG, Daffner SD, et al. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 2003;28:134-139
13. Younger E.M., Chapman M.W. Morbidity at bon-grafting for the treatment of kyphosis. Review of experience with forty-eight patients. J Bone Joint Surg Am 1982;64:680-690.
14. Jones J, Yoo J, Hart R. Delayed fracture of fibular strut allograft following multilevel anterior cervical spine corpectomy and fusion. Spine 2006;31: E595-9.
15. McKenna PJ, Freeman BJ, Mulholland RC, et al. A prospective, randomised controlled trial of femoral ring allograft versus a titanium cage in circumferential lumbar spinal fusion with minimum 2-year clinical results. Eur Spine J 2005;14:727-737
16. McKoy BE, Wingate JK, Poletti SC, et al. Fibular allograft after anterior cervical corpectomy: long term follow-up. Iowa Orthop J 2002;22:42-46
17. Munting E, Faundez A, Manche E. Vertebral reconstruction with cortical allograft: long-term evaluation. Eur Spine J 2001;10(suppl 2):S153-7.
18. Singh K, DeWald CJ, Hammerberg KW, et al. Long structural allografts in the treatment of anterior spinal column defects. Clin Orthop Relat Res 2002: 121-129
19. Thongtrangan I, Balabhadra RS, Kim DH. Management of strut graft failure in anterior cervical spine surgery. Neurosurg Focus 2003;15:E4.
20. Zdeblick TA, Ducker TB. The use of freeze-dried allograft bone for anterior cervical fusions. Spine 1991;16:726-729
21. Zdeblick TA, Hughes SS, Riew KD, et al. Failed anterior cervical discectomy and arthrodesis. Analysis and treatment of thirty-five patients. J Bone Joint Surg Am 1997;79:523-532
22. Lord CF, Gebhardt MC, Tomford WW, et al. Infection in bone allografts. Incidence, nature, and treatment. J Bone Joint Surg Am 1988;70:369-376
23. Burchardt H. The biology of bone graft repair. Clin Orthop Relat Res 1983: 28-42.
24. Burchardt H. Biology of bone transplantation. Orthop Clin North Am 1987; 18:187-196
25. Garbuz DS, Masri BA, Czitrom AA. Biology of allografting. Orthop Clin North Am 1998;29:199-204.
26. Stevenson S. Biology of bone grafts. Orthop Clin North Am 1999;30: 543-552
27. Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 2000:10-27.
28. Tiyapatanaputi P, Rubery PT, Carmouche J, et al. A novel murine segmental femoral graft model. J Orthop Res 2004;22:1254-1260
29. Karaoglu S, Baktir A, Kabak S, et al. Experimental repair of segmental bone defects in rabbits by demineralized allograft covered by free autogenous periosteum. Injury 2002;33:679-683
30. Liu JY, Wang D, Cheng HH. Use of revascularized periosteal allografts for repairing bony defects: an experimental study. Microsurgery 1994;15:93-97
31. Zhang X, Xie C, Lin AS, et al. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res 2005;20:2124-2137
32. Akahane M, Ohgushi H, Yoshikawa T, et al. Osteogenic phenotype expression of allogeneic rat marrow cells in porous hydroxyapatite ceramics. J Bone Miner Res 1999;14:561-568
33. Cinotti G, Patti AM, Vulcano A, et al. Experimental posterolateral spinal fusion with porous ceramics and mesenchymal stem cells. J Bone Joint Surg Br 2004;86:135-142
34. Erbe EM, Marx JG, Clineff TD, et al. Potential of an ultraporous betatricalcium phosphate synthetic cancellous bone void filler and bone marrow aspirate composite graft. Eur Spine J 2001;10(suppl 2):S141-6.
35. Hardouin P, Anselme K, Flautre B, et al. Tissue engineering and skeletal diseases. Joint Bone Spine 2000;67:419-424
36. Minamide A, Yoshida M, Kawakami M, et al. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion. Spine 2007;32:1067-1071
37. Muschler GF, Nitto H, Matsukura Y, et al. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop Relat Res 2003:102-118
38. Nakajima T, Iizuka H, Tsutsumi S, et al. Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation. Spine 2007;32:2432-2436
39. Neen D, Noyes D, Shaw M, et al. Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft. Spine 2006;31:E636-40.
40. Nelson ER, Huang Z, Ma T, et al. New bone formation by murine osteoprogenitor cells cultured on corticocancellous allograft bone. J Orthop Res 2008;26:1660-1664
41. Soltan M, Smiler D, Prasad HS, et al. Bone block allograft impregnated with bone marrow aspirate. Implant Dent 2007;16:329-339
42. Xie C, Reynolds D, Awad H, et al. Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering. Tissue Eng 2007;13:435-445
43. Reynolds DG, Hock C, Shaikh S, et al. Micro-computed tomography prediction of biomechanical strength in murine structural bone grafts. J Biomech 2007;40:3178-3186
44. Kimelman N, Pelled G, Helm GA, et al. Review: gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng 2007;13:1135-1150
45. Nixon AJ, Goodrich LR, Scimeca MS, et al. Gene therapy in musculoskeletal repair. Ann N Y Acad Sci 2007;1117:310-327
46. Phillips JE, Gersbach CA, Garcia AJ. Virus-based gene therapy strategies for bone regeneration. Biomaterials 2007;28:211-229
47. Yoon ST, Boden SD. Spine fusion by gene therapy. Gene Ther 2004;11:360-367
48. Baltzer AW, Lieberman JR. Regional gene therapy to enhance bone repair. Gene Ther 2004;11:344-350
49. Carofino BC, Lieberman JR. Gene therapy applications for fracture-healing. J Bone Joint Surg Am 2008;90(suppl 1):99-110.
50. Evans CH, Ghivizzani SC, Herndon JH, et al. Gene therapy for the treatment of musculoskeletal diseases. J Am Acad Orthop Surg 2005;13:230-242
51. Giannoudis PV, Tzioupis CC, Tsiridis E. Gene therapy in orthopaedics. Injury 2006;37(suppl 1):S30-40.
52. Kang R, Ghivizzani SC, Muzzonigro TS, et al. The Marshall R. Urist Young Investigator Award. Orthopaedic applications of gene therapy. From concept to clinic. Clin Orthop Relat Res 2000:324-337
53. Schwarz EM. The adeno-associated virus vector for orthopaedic gene therapy. Clin Orthop Relat Res 2000:S31-9.
54. Ito H, Koefoed M, Tiyapatanaputi P, et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 2005;11:291-297
55. Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006;38:525-527
56. Koefoed M, Ito H, Gromov K, et al. Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther 2005;12:212-218